etomidate
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
15 FDA-registered drug labelers
Armas Pharmaceuticals Inc.
Bachem SA, succursale de Vionnaz
Caplin Steriles Limited
Civica, Inc.
Eugia US LLC
Fosun Pharma USA Inc
Fresenius Kabi USA, LLC
Gland Pharma Limited
Henry Schein, Inc.
HF Acquisition Co LLC, DBA HealthFirst
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Huzhou Zhanwang Pharmaceutical Co., Ltd.
Mylan Institutional LLC
Pisgah Labs, Incorporated
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •Etomidate
- •Etomidate injection, solution
- •Amidate
- •Amidate(TM) Etomidate
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Etomidate Injection
10/05/2022Available
current
Etomidate Injection
10/05/2022Unavailable
Chemical Identity
CAS33125-97-2
PubChem CID667484
DTXSIDDTXSID5023033
FormulaC14H16N2O2
Mol. Weight244.29 g/mol
SMILESCCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
Data Sources
6674842026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/etomidate/cids/JSON
Archive: data/sources/pubchem_name/etomidate.json
CAS 33125-97-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 33125-97-22026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json